Local view for "https://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/Evidence/1475"
| Predicate | Value (sorted: none) |
|---|---|
| rdf:type | |
| rdf:type | |
| rdfs:label |
"evidence_1167"
|
| ?:Evidence_type | |
| ?:Evidence_enzyme_system | |
| dc:creator | |
| dc:date |
"11/09/2009 12:18:41"
|
| ?:content |
"Elimination
After oral administration, eszopiclone is eliminated with a mean t1/2 of approximately 6 hours. Up to 75% of an oral dose of racemic zopiclone is excreted in the urine, primarily as metabolites. A similar excretion profile would be expected for eszopiclone, the S-isomer of racemic zopiclone. Less than 10% of the orally administered eszopiclone dose is excreted in the urine as parent drug."
|
| rdfs:seeAlso |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/dikb.ttl
The resource appears as object in one triple:
{ eszopiclone_primary_total_clearance_mechanism_Renal_Excretion, <http://purl.org/swan/1.2/swan-commons#citesAsRefutingEvidence>, evidence_1167 }